Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: UROKINASE TYPE PLASMINOGEN ACTIVATOR, . Treffer: 7

2018

Santibanez, JF; Krstic, J Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
Curr Protein Pept Sci. 2018; 19(12):1155-1163
Web of Science PubMed FullText FullText_MUG

 

2015

Krstić, J; Obradović, H; Jauković, A; Okić-Đorđević, I; Trivanović, D; Kukolj, T; Mojsilović, S; Ilić, V; Santibañez, JF; Bugarski, D Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
Biochim Biophys Acta. 2015; 1853(2): 431-444. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Krstic, J; Maslovaric, I; Santibanez, JF Novel patents and cancer therapies for transforming growth factor-beta and urokinase type plasminogen activator: potential use of their interplay in tumorigenesis.
Recent Pat Anticancer Drug Discov. 2014; 9(3): 354-371.
Web of Science PubMed FullText FullText_MUG

 

2013

Kocić, J; Santibañez, JF; Krstić, A; Mojsilović, S; Ilić, V; Bugarski, D Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase.
Int J Biochem Cell Biol. 2013; 45(2): 464-475.
Web of Science PubMed FullText FullText_MUG

 

2012

Kocic, J; Bugarski, D; Santibanez, JF SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Eur J Cancer. 2012; 48(10): 1550-1557.
Web of Science PubMed FullText FullText_MUG

 

2010

Villar, V; Kocic, J; Bugarski, D; Jovcic, G; Santibanez, JF SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes.
FEBS Lett. 2010; 584(22):4586-4592
Web of Science PubMed FullText FullText_MUG

 

2002

Bader, AA; Tio, J; Petru, E; Bühner, M; Pfahlberg, A; Volkholz, H; Tulusan, AH T1 breast cancer: identification of patients at low risk of axillary lymph node metastases.
Breast Cancer Res Treat. 2002; 76(1):11-17
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum